Cargando…
Molecular Dynamics Simulation of HIV Fusion Inhibitor T-1249: Insights on Peptide-Lipid Interaction
T-1249 is a peptide that inhibits the fusion of HIV envelope with the target cell membrane. Recent results indicate that T-1249, as in the case of related inhibitor peptide T-20 (enfuvirtide), interacts with membranes, more extensively in the bilayer liquid disordered phase than in the liquid ordere...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3364549/ https://www.ncbi.nlm.nih.gov/pubmed/22675399 http://dx.doi.org/10.1155/2012/151854 |
_version_ | 1782234552637325312 |
---|---|
author | Martins do Canto, A. M. T. Palace Carvalho, A. J. Prates Ramalho, J. P. Loura, Luís M. S. |
author_facet | Martins do Canto, A. M. T. Palace Carvalho, A. J. Prates Ramalho, J. P. Loura, Luís M. S. |
author_sort | Martins do Canto, A. M. T. |
collection | PubMed |
description | T-1249 is a peptide that inhibits the fusion of HIV envelope with the target cell membrane. Recent results indicate that T-1249, as in the case of related inhibitor peptide T-20 (enfuvirtide), interacts with membranes, more extensively in the bilayer liquid disordered phase than in the liquid ordered state, which could be linked to its effectiveness. Extensive molecular dynamics simulations (100 ns) were carried out to investigate the interaction between T-1249 and bilayers of 1-palmitoyl-2-oleoyl-phosphatidylcholine (POPC) and POPC/cholesterol (1 : 1). It was observed that T-1249 interacts to different extents with both membrane systems and that peptide interaction with the bilayer surface has a local effect on membrane structure. Formation of hydrogen bonding between certain peptide residues and several acceptor and donor groups in the bilayer molecules was observed. T-1249 showed higher extent of interaction with bilayers when compared to T-20. This is most notable in POPC/Chol membranes, owing to more peptide residues acting as H bond donors and acceptors between the peptide and the bilayer lipids, including H-bonds formed with cholesterol. This behavior is at variance with that of T-20, which forms no H bonds with cholesterol. This higher ability to interact with membranes is probably correlated with its higher inhibitory efficiency. |
format | Online Article Text |
id | pubmed-3364549 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-33645492012-06-06 Molecular Dynamics Simulation of HIV Fusion Inhibitor T-1249: Insights on Peptide-Lipid Interaction Martins do Canto, A. M. T. Palace Carvalho, A. J. Prates Ramalho, J. P. Loura, Luís M. S. Comput Math Methods Med Research Article T-1249 is a peptide that inhibits the fusion of HIV envelope with the target cell membrane. Recent results indicate that T-1249, as in the case of related inhibitor peptide T-20 (enfuvirtide), interacts with membranes, more extensively in the bilayer liquid disordered phase than in the liquid ordered state, which could be linked to its effectiveness. Extensive molecular dynamics simulations (100 ns) were carried out to investigate the interaction between T-1249 and bilayers of 1-palmitoyl-2-oleoyl-phosphatidylcholine (POPC) and POPC/cholesterol (1 : 1). It was observed that T-1249 interacts to different extents with both membrane systems and that peptide interaction with the bilayer surface has a local effect on membrane structure. Formation of hydrogen bonding between certain peptide residues and several acceptor and donor groups in the bilayer molecules was observed. T-1249 showed higher extent of interaction with bilayers when compared to T-20. This is most notable in POPC/Chol membranes, owing to more peptide residues acting as H bond donors and acceptors between the peptide and the bilayer lipids, including H-bonds formed with cholesterol. This behavior is at variance with that of T-20, which forms no H bonds with cholesterol. This higher ability to interact with membranes is probably correlated with its higher inhibitory efficiency. Hindawi Publishing Corporation 2012 2012-05-22 /pmc/articles/PMC3364549/ /pubmed/22675399 http://dx.doi.org/10.1155/2012/151854 Text en Copyright © 2012 A. M. T. Martins do Canto et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Martins do Canto, A. M. T. Palace Carvalho, A. J. Prates Ramalho, J. P. Loura, Luís M. S. Molecular Dynamics Simulation of HIV Fusion Inhibitor T-1249: Insights on Peptide-Lipid Interaction |
title | Molecular Dynamics Simulation of HIV Fusion Inhibitor T-1249: Insights on Peptide-Lipid Interaction |
title_full | Molecular Dynamics Simulation of HIV Fusion Inhibitor T-1249: Insights on Peptide-Lipid Interaction |
title_fullStr | Molecular Dynamics Simulation of HIV Fusion Inhibitor T-1249: Insights on Peptide-Lipid Interaction |
title_full_unstemmed | Molecular Dynamics Simulation of HIV Fusion Inhibitor T-1249: Insights on Peptide-Lipid Interaction |
title_short | Molecular Dynamics Simulation of HIV Fusion Inhibitor T-1249: Insights on Peptide-Lipid Interaction |
title_sort | molecular dynamics simulation of hiv fusion inhibitor t-1249: insights on peptide-lipid interaction |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3364549/ https://www.ncbi.nlm.nih.gov/pubmed/22675399 http://dx.doi.org/10.1155/2012/151854 |
work_keys_str_mv | AT martinsdocantoamt moleculardynamicssimulationofhivfusioninhibitort1249insightsonpeptidelipidinteraction AT palacecarvalhoaj moleculardynamicssimulationofhivfusioninhibitort1249insightsonpeptidelipidinteraction AT pratesramalhojp moleculardynamicssimulationofhivfusioninhibitort1249insightsonpeptidelipidinteraction AT louraluisms moleculardynamicssimulationofhivfusioninhibitort1249insightsonpeptidelipidinteraction |